KRT5 and breast cancer: Further evaluation of breast cancer-associated markers (ER, HER2, Ki67, p53, vimentin, CK5/6, CK8/18) revealed IHC diversity across the PDX library, with striking similarities between parental tumors and PDXs (Fig. 1e, Supplementary Fig. 3).